$BUJA
Bukit Jalil Global Acquisition 1 Ltd. Stock $buja

$buja Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000192998024000358 Filed on August 15, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$0.00		$130.0K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$444.5K	$238.0K	$130.0K
YoY Change	74.21%	83.08%
Operating Profit	-$444.5K	-$238.0K	-$129.4K
YoY Change	74.22%	83.89%
Interest Expense	$444.2K	$789.8K	$0.00
YoY Change	-39.82%
% of Operating Profit
Other Income/Expense, Net			$1.540M
YoY Change
Pretax Income	-$320.00	$551.8K	-$130.0K
YoY Change	-100.07%	-524.47%
Income Tax
% Of Pretax Income
Net Earnings	-$323.00	$551.8K	-$129.3K
YoY Change	-100.07%	-526.85%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.00	$0.07	-$0.09
COMMON SHARES
Basic Shares Outstanding	4.941M shares	7.762M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$215.8K	$54.47K	$680.0K
YoY Change	-39.24%	-91.99%
Cash & Equivalents	$215.8K	$54.47K	$681.6K
Short-Term Investments
Other Short-Term Assets	$44.42K	$76.83K	$120.0K
YoY Change	-65.17%	-35.98%
Inventory
Prepaid Expenses	$44.42K	$76.83K
Receivables
Other Receivables
Total Short-Term Assets	$260.2K	$131.3K	$800.0K
YoY Change	-46.09%	-83.59%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$32.15M	$61.46M	$58.36M
YoY Change	-45.61%	5.3%
Other Assets
YoY Change
Total Long-Term Assets	$32.15M	$61.46M	$58.36M
YoY Change	-45.61%	5.3%
TOTAL ASSETS
Total Short-Term Assets	$260.2K	$131.3K	$800.0K
Total Long-Term Assets	$32.15M	$61.46M	$58.36M
Total Assets	$32.41M	$61.59M	$59.16M
YoY Change	-45.61%	4.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$209.4K	$199.0K	$140.0K
YoY Change	43.09%	42.15%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$400.0K	$133.0K	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.336M	$362.5K	$150.0K
YoY Change	725.69%	141.69%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.150M	$1.150M	$1.150M
YoY Change	0.0%	0.0%
Total Long-Term Liabilities	$1.150M	$1.150M	$1.150M
YoY Change	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.336M	$362.5K	$150.0K
Total Long-Term Liabilities	$1.150M	$1.150M	$1.150M
Total Liabilities	$2.486M	$1.513M	$1.300M
YoY Change	89.51%	16.35%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.226M	-$1.381M	-$147.5K
YoY Change		836.65%
Common Stock	$202.00	$202.00	$202.00
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.226M	-$1.381M	$9.747M
YoY Change
Total Liabilities & Shareholders Equity	$32.41M	$61.59M	$59.16M
YoY Change	-45.61%	4.09%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$323.00	$551.8K	-$129.3K
YoY Change	-100.07%	-526.85%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$401.7K	-$110.1K	-$180.0K
YoY Change	24.89%	-38.86%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$29.75M	$0.00	-$58.36M
YoY Change	-1190242.0%	-100.0%
Cash From Investing Activities	$29.75M	$0.00	-$58.36M
YoY Change	-1190242.0%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-29.19M	133.0K	59.13M
YoY Change	3891973.33%	-99.78%
NET CHANGE
Cash From Operating Activities	-401.7K	-110.1K	-180.0K
Cash From Investing Activities	29.75M	0.000	-58.36M
Cash From Financing Activities	-29.19M	133.0K	59.13M
Net Change In Cash	161.3K	22.95K	590.0K
YoY Change	-149.65%	-96.11%
FREE CASH FLOW
Cash From Operating Activities	-$401.7K	-$110.1K	-$180.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Furthermore, bank failures, non-performance, or other adverse developments that affect financial institutions could impair the ability of one or more of the banks participating in the credit facility from honoring their commitments. Such events could have a material adverse effect on the Company’s financial condition or results of operations.</p>
	dei	Entity Central Index Key EntityCentralIndexKey	0001956055
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Temporary Equity Share Subscriptions TemporaryEquityShareSubscriptions	5750000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	490000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2011807	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2011807	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2011807	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2875000	shares
CY2024Q2	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	2011807	shares
CY2023Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	2011807	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41729
	dei	Entity Registrant Name EntityRegistrantName	BUKIT JALIL GLOBAL ACQUISITION 1 LTD.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
	dei	Entity Address Address Line1 EntityAddressAddressLine1	31-1 Taman Miharja Phase 3B
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Jalan 3/93
	dei	Entity Address Address Line3 EntityAddressAddressLine3	2 ½ Miles, Cheras
	dei	Entity Address City Or Town EntityAddressCityOrTown	Kuala Lumpur
	dei	Entity Address Country EntityAddressCountry	MY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55200
	dei	City Area Code CityAreaCode	603
	dei	Local Phone Number LocalPhoneNumber	91339688
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4941322	shares
CY2024Q2	us-gaap	Cash Cash	54466	usd
CY2023Q4	us-gaap	Cash Cash	295372	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	76834	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	101684	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	131300	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	397056	usd
CY2024Q2	us-gaap	Investments Investments	61455203	usd
CY2023Q4	us-gaap	Investments Investments	59884239	usd
CY2024Q2	us-gaap	Assets Assets	61586503	usd
CY2023Q4	us-gaap	Assets Assets	60281295	usd
CY2024Q2	bukit	Due To Related Party Current DueToRelatedPartyCurrent	30524	usd
CY2023Q4	bukit	Due To Related Party Current DueToRelatedPartyCurrent	38676	usd
CY2024Q2	bukit	Sponsor Loan SponsorLoan	133000	usd
CY2024Q2	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	199014	usd
CY2023Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	118920	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	362538	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	157596	usd
CY2024Q2	bukit	Deferred Underwriters Discountnoncurrent DeferredUnderwritersDiscountnoncurrent	1150000	usd
CY2023Q4	bukit	Deferred Underwriters Discountnoncurrent DeferredUnderwritersDiscountnoncurrent	1150000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	1512538	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1307596	usd
CY2024Q2	us-gaap	Temporary Equity Share Subscriptions TemporaryEquityShareSubscriptions	5750000	shares
CY2024Q2	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	61455203	usd
CY2023Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	54526904	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	490000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2011807	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	202	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	202	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	0	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4446593	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1381440	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	0	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-1381238	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	4446795	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	61586503	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	60281295	usd
CY2024Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	238012	usd
CY2023Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	4081	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	470697	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	4138	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	125350	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	125350	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-238012	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-129431	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-470697	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-129488	usd
CY2024Q2	us-gaap	Interest Income Other InterestIncomeOther	0	usd
CY2023Q2	us-gaap	Interest Income Other InterestIncomeOther	157	usd
	us-gaap	Interest Income Other InterestIncomeOther	0	usd
	us-gaap	Interest Income Other InterestIncomeOther	504	usd
CY2024Q2	us-gaap	Investment Income Dividend InvestmentIncomeDividend	789818	usd
CY2023Q2	us-gaap	Investment Income Dividend InvestmentIncomeDividend	0	usd
	us-gaap	Investment Income Dividend InvestmentIncomeDividend	1570964	usd
	us-gaap	Investment Income Dividend InvestmentIncomeDividend	0	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	551806	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-129274	usd
	us-gaap	Net Income Loss NetIncomeLoss	1100267	usd
	us-gaap	Net Income Loss NetIncomeLoss	-128984	usd
CY2024Q2	bukit	Weighted Average Ordinary Shares Outstanding Basic And Diluted WeightedAverageOrdinarySharesOutstandingBasicAndDiluted	5750000	shares
CY2023Q2	bukit	Weighted Average Ordinary Shares Outstanding Basic And Diluted WeightedAverageOrdinarySharesOutstandingBasicAndDiluted	63187	shares
	bukit	Weighted Average Ordinary Shares Outstanding Basic And Diluted WeightedAverageOrdinarySharesOutstandingBasicAndDiluted	5750000	shares
	bukit	Weighted Average Ordinary Shares Outstanding Basic And Diluted WeightedAverageOrdinarySharesOutstandingBasicAndDiluted	31768	shares
CY2024Q2	bukit	Earning Per Ordinary Shares Basic And Diluted EarningPerOrdinarySharesBasicAndDiluted	0.23
CY2023Q2	bukit	Earning Per Ordinary Shares Basic And Diluted EarningPerOrdinarySharesBasicAndDiluted	-0.09
	bukit	Earning Per Ordinary Shares Basic And Diluted EarningPerOrdinarySharesBasicAndDiluted	0.45
	bukit	Earning Per Ordinary Shares Basic And Diluted EarningPerOrdinarySharesBasicAndDiluted	-0.09
CY2024Q2	bukit	Weighted Average Number Of Ordinary Shares Outstanding Basic And Diluted WeightedAverageNumberOfOrdinarySharesOutstandingBasicAndDiluted	2011807	shares
CY2023Q2	bukit	Weighted Average Number Of Ordinary Shares Outstanding Basic And Diluted WeightedAverageNumberOfOrdinarySharesOutstandingBasicAndDiluted	1443811	shares
	bukit	Weighted Average Number Of Ordinary Shares Outstanding Basic And Diluted WeightedAverageNumberOfOrdinarySharesOutstandingBasicAndDiluted	2011807	shares
	bukit	Weighted Average Number Of Ordinary Shares Outstanding Basic And Diluted WeightedAverageNumberOfOrdinarySharesOutstandingBasicAndDiluted	1440673	shares
CY2024Q2	bukit	Basic And Diluted Net Loss Per Ordinary Share Attributable To Non Redeemable Ordinary Shares BasicAndDilutedNetLossPerOrdinaryShareAttributableToNonRedeemableOrdinaryShares	-0.38
CY2023Q2	bukit	Basic And Diluted Net Loss Per Ordinary Share Attributable To Non Redeemable Ordinary Shares BasicAndDilutedNetLossPerOrdinaryShareAttributableToNonRedeemableOrdinaryShares	-0.09
	bukit	Basic And Diluted Net Loss Per Ordinary Share Attributable To Non Redeemable Ordinary Shares BasicAndDilutedNetLossPerOrdinaryShareAttributableToNonRedeemableOrdinaryShares	-0.75
	bukit	Basic And Diluted Net Loss Per Ordinary Share Attributable To Non Redeemable Ordinary Shares BasicAndDilutedNetLossPerOrdinaryShareAttributableToNonRedeemableOrdinaryShares	-0.09
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	4446795	usd
CY2024Q1	bukit	Accretion Of Ordinary Share Subject To Redemption Value AccretionOfOrdinaryShareSubjectToRedemptionValue	-3395348	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	548461	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	1599908	usd
CY2024Q2	bukit	Accretion Of Ordinary Share Subject To Redemption Value AccretionOfOrdinaryShareSubjectToRedemptionValue	-3532952	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	551806	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-1381238	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6496	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	290	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	6786	usd
CY2023Q2	bukit	Sale Of Public Units Through Public Offering Amount SaleOfPublicUnitsThroughPublicOfferingAmount	57500000	usd
CY2023Q2	bukit	Sale Of Private Placement Shares Amount SaleOfPrivatePlacementSharesAmount	4243070	usd
CY2023Q2	bukit	Issuance Of Representative Shares Amount IssuanceOfRepresentativeSharesAmount	817500	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	125350	usd
CY2023Q2	bukit	Underwriters Discount UnderwritersDiscount	-3162500	usd
CY2023Q2	us-gaap	Other Expenses OtherExpenses	1540024	usd
CY2023Q2	bukit	Reclassification Of Ordinary Shares Subject To Redemption Amount ReclassificationOfOrdinarySharesSubjectToRedemptionAmount	-52350300	usd
CY2023Q2	bukit	Allocation Of Offering Costs To Ordinary Shares Subject To Redemption AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption	4236160	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-129274	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	9746768	usd
	us-gaap	Profit Loss ProfitLoss	1100267	usd
	us-gaap	Profit Loss ProfitLoss	-128984	usd
	bukit	Dividend Income On Investments Held In Trust DividendIncomeOnInvestmentsHeldInTrust	-1570964	usd
	bukit	Dividend Income On Investments Held In Trust DividendIncomeOnInvestmentsHeldInTrust	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	125350	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	0	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	70278	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	24850	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-120000	usd
	bukit	Increase Decrease In Due To Related Party Payable IncreaseDecreaseInDueToRelatedPartyPayable	-8152	usd
	bukit	Increase Decrease In Due To Related Party Payable IncreaseDecreaseInDueToRelatedPartyPayable	0	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	80094	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-51760	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-373905	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-105116	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	58362500	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-58362500	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	55487500	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	4243070	usd
	bukit	Proceeds Fromissuance Of Related Party Debt ProceedsFromissuanceOfRelatedPartyDebt	0	usd
	bukit	Proceeds Fromissuance Of Related Party Debt ProceedsFromissuanceOfRelatedPartyDebt	168135	usd
	bukit	Repayments Ofissuance Of Related Party Debt RepaymentsOfissuanceOFRelatedPartyDebt	0	usd
	bukit	Repayments Ofissuance Of Related Party Debt RepaymentsOfissuanceOFRelatedPartyDebt	433508	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	133000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	15438	usd
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	0	usd
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	331388	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	133000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	59149247	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-240905	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	681631	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	295372	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	54466	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	681631	usd
	bukit	Non Cash Deferred Offering Costs Included In Accrued Expenses NonCashDeferredOfferingCostsIncludedInAccruedExpenses	0	usd
	bukit	Non Cash Deferred Offering Costs Included In Accrued Expenses NonCashDeferredOfferingCostsIncludedInAccruedExpenses	134285	usd
	bukit	Noncashdeferred Offering Costs Paid By Promissory Note NoncashdeferredOfferingCostsPaidByPromissoryNote	7147	usd
	bukit	Noncashdeferred Underwriters Discount NoncashdeferredUnderwritersDiscount	0	usd
	bukit	Noncashdeferred Underwriters Discount NoncashdeferredUnderwritersDiscount	1150000	usd
	bukit	Non Cash Representative Shares Issued NonCashRepresentativeSharesIssued	817500	usd
	bukit	Non Cash Allocation Of Offering Costs To Ordinary Shares Subject To Redemption NonCashAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption	0	usd
	bukit	Non Cash Allocation Of Offering Costs To Ordinary Shares Subject To Redemption NonCashAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption	4236160	usd
	bukit	Noncashaccretion Of Ordinary Shares Subject To Redemption Value NoncashaccretionOfOrdinarySharesSubjectToRedemptionValue	6928300	usd
	bukit	Noncashaccretion Of Ordinary Shares Subject To Redemption Value NoncashaccretionOfOrdinarySharesSubjectToRedemptionValue	0	usd
CY2024Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2011807	shares

Files In Submission

Name	View Source	Status
0001929980-24-000358-index-headers.html	Edgar Link	pending
0001929980-24-000358-index.html	Edgar Link	pending
0001929980-24-000358.txt	Edgar Link	pending
0001929980-24-000358-xbrl.zip	Edgar Link	pending
bukit-20240630.xsd	Edgar Link	pending
bukit_10q.htm	Edgar Link	pending
bukit_ex311.htm	Edgar Link	pending
bukit_ex321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
bukit-20240630_lab.xml	Edgar Link	unprocessable
bukit-20240630_pre.xml	Edgar Link	unprocessable
bukit-20240630_def.xml	Edgar Link	unprocessable
bukit-20240630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bukit_10q_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BUJA
Bukit Jalil Global Acquisition 1 Ltd. Stock $buja

2024 Q3 Form 10-Q Financial Statement

#000192998024000358 Filed on August 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BUJA Bukit Jalil Global Acquisition 1 Ltd. Stock $buja

2024 Q3 Form 10-Q Financial Statement

#000192998024000358 Filed on August 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BUJA
Bukit Jalil Global Acquisition 1 Ltd. Stock $buja